Aadi Bioscience (NASDAQ:AADI) just reported results for the first quarter of 2024.
- Aadi Bioscience reported earnings per share of -68 cents. This was below the analyst estimate for EPS of -64 cents.
- The company reported revenue of $5.35 million.
- This was 17.01% worse than the analyst estimate for revenue of $6.45 million.